The presence or absence of hormonal receptors can significantly influence treatment decisions. For instance, cancers that are ER or PR positive are often treated with hormone therapies aimed at blocking these receptors. In contrast, cancers lacking these receptors may require different therapeutic approaches, such as chemotherapy or targeted therapies.
